Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$3.99 - $17.73 $51,072 - $226,944
-12,800 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$11.19 - $16.92 $14,547 - $21,996
-1,300 Reduced 9.22%
12,800 $28,000
Q2 2020

Aug 10, 2020

SELL
$4.42 - $12.66 $16,354 - $46,842
-3,700 Reduced 20.79%
14,100 $35,000
Q1 2020

May 08, 2020

BUY
$4.01 - $8.88 $71,378 - $158,064
17,800 New
17,800 $31,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $75.9M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.